The DOI matches its Crossref record.
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Abstract
(-)-Nicotine, the prototypical agonist for neuronal nicotinic acetylcholine receptors (nAChR) has been shown to bind with high affinity to the rodent and avian alpha 4 beta 2 nAChR subtype. This subtype may represent a primary molecular target for some of the beneficial central nervous system effects i.e., cognitive enhancement, anxiolysis, analgesia, neuroprotection, of (-)-nicotine and related ligands. However, a detailed study of the human alpha 4 beta 2 subunit combination has not yet been reported. In this study, we stably coexpressed the human neuronal alpha 4 and beta 2 nAChR subunits in human embryonic kidney (HEK) 293 cells and studied its pharmacological and regulatory properties. [3H]Cytisine bound to stably transfected cells with high affinity (KD value, 0.2 +/- 0.04 nM) and with a Bmax value of 1359 +/- 91 fmol/mg protein. A good correlation (r = 0.98) was observed between binding affinities in transfected cells and in native neuronal preparations for a series of nAChR ligands. 86Rb+ efflux studies showed that stably transfected cells express functional ion channels that are sensitive to blockade by dihydro-beta-erythroidine. (+/-)-Epibatidine, (-)-nicotine, 1,1-dimethyl-4-phenylpiperazinium, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT-418), acetylcholine and (-)-cytisine stimulated 86Rb+ efflux with EC50 values of 0.02, 3.9, 2.5, 10, 44 and 38 microM, respectively. Treatment of transfected cells with (-)-nicotine for 7 days led to a significant increase in the density of [3H](-)-cytisine binding sites (EC50 = 0.56 microM) and a significant enhancement in the sensitivity of ACh. Specific binding or (-)-nicotine-evoked cation efflux was not detected in untransfected cells. Analysis of total cellular RNA from transfected, but not untransfected cells, showed the expected fragment sizes corresponding to the human alpha 4 and beta 2 subunit mRNA. These results demonstrate that stable expression of the human alpha 4 beta 2 nAChR subunit combination can give rise to functional ion channels that bind [3H](-)-cytisine with high affinity, exhibit homologous regulation and evoke agonist-induced cation flux with pharmacological properties consistent with native neuronal alpha 4 beta 2 nAChR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequently, however, increased responses reflecting the increased receptors are usually found (Rowell and Wonnacott, 1990;Benwell et al., 1995;Gopalakrishnan et al., 1996Gopalakrishnan et al., , 1997;;Buisson and Bertrand, 2001;Avila et al., 2003)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Gopalakrishnan et al., 1996
In the citing paper
“The α4β2 receptors exist in a mixed population whose nicotine EC50 values differ by 50- to 100-fold (70–73) (~1 and ~100 μM).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [70]
Citations
Cited by
Sorted by citations
Items 101–181 of 181
Kuntzweiler, T. A., Arnerić, S. P., & Donnelly‐Roberts, D. L. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199805)44:1 · Cited by 38
Mashimo, M., Iwasaki, Y., Inoue, S., Saito, S., Kawashima, K., & Fujii, T. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.015 · Cited by 37
Avalos, M., Parker, M. J., Maddox, F. N., Carroll, F. I., & Luetje, C. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035899 · Cited by 36
Benallegue, N., Mazzaferro, S., Alcaino, C., & Bermúdez, I. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12268 · Cited by 36
The fall and rise of pharmacology – (Re-)defining the discipline?
Winquist, R. J., Mullane, K., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.011 · Cited by 39
Fitch, R. W., Kaneko, Y., Klaperski, P., Daly, J. W., SEITZ, G., & Gündisch, D. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.073 · Cited by 35
Hussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
Briggs, C. A., Gubbins, E. J., Marks, M. J., Putman, C. B., Thimmapaya, R., Meyer, M. D., & Surowy, C. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020198 · Cited by 33
Marks, M. J., Meinerz, N. M., Brown, R. W. B., & Collins, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.040 · Cited by 33
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Jacobs, I. C., Anderson, D. J., Surowy, C. S., & Puttfarcken, P. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00166-1 · Cited by 33
Dourado, M., & Sargent, P. B. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.3117 · Cited by 33
Narahashi, T. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.2.193 · Cited by 34
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic α4β2 Receptors
Kishi, M., & Steinbach, J. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029298 · Cited by 31
Depressant and Convulsant Barbiturates Both Inhibit Neuronal Nicotinic Acetylcholine Receptors
Watanabe, I., Andoh, T., Furuya, R., Sasaki, T., Kamiya, Y., & Itoh, H. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199906000-00038 · Cited by 31
Pathophysiology and Clinical Implications
Shi, Y., Weingarten, T. N., Mantilla, C. B., Hooten, W. M., & Warner, D. O. (2010) · Cited by 30
Zhang, J., & Steinbach, J. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03733-2 · Cited by 30
Hosur, V., Leppanen, S., Taha, A. A., & Loring, R. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06373.x · Cited by 29
Structure-Based Design and Discovery of New M2Receptor Agonists
Fish, I., Stößel, A., Eitel, K., Valant, C., Albold, S., Huebner, H., Möller, D., Clark, M. J., Sunahara, R. K., Christopoulos, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01113 · Cited by 29
Li, S., Wu, M., Wang, X., Yuan, L., Yang, D. U., & Qi, J. (2011) · Synapse · doi:10.1002/syn.20951 · Cited by 30
[2] Fluorescence techniques for measuring ion channel activity
Veliçelebi, G., Stauderman, K. A., Varney, M. A., AKONG, M., Hess, S. D., & Johnson, E. C. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)94005-3 · Cited by 29
Recent developments in neuronal nicotinic acetylcholine receptor modulators
Lin, N., & Meyer, M. D. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.8.991 · Cited by 29
Dávila‐García, M. I., Houghtling, R. A., Qasba, S. S., & Kellar, K. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00344-1 · Cited by 28
Liu, Q., Yu, K., Chang, Y., Lukas, R. J., & Wu, J. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00760.x · Cited by 25
Some Methods for Studies of Nicotinic Acetylcholine Receptor Pharmacology
Lukas, R. J., Fryer, J. D., Eaton, J. B., & Gentry, C. L. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.sec1 · Cited by 25
Novel nicotine analogues with potential anti-mycobacterial activity
Gandhi, P. T., Athmaram, T. N., & Arunkumar, G. R. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.02.035 · Cited by 22
Characterization of Human α4β2 Neuronal Nicotinic Receptors Stably Expressed in SH-EP1 Cells
Pacheco, M. A., Pastoor, T. E., Lukas, R. J., & Wecker, L. (2001) · Neurochemical Research · doi:10.1023/a:1010995521851 · Cited by 22
Jacob, N. T., Lockner, J. W., Schlosburg, J. E., Ellis, B. A., Eubanks, L. M., & Janda, K. D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01676 · Cited by 21
Ohtani, M., Oka, T., Badyuk, M., Xiao, Y., Kellar, K. J., & Daly, J. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014902 · Cited by 20
Pseudophrynaminol: A potent noncompetitive blocker of nicotinic receptor-channels
Badio, B., Garraffo, H. M., Padgett, W. L., Greig, N. H., & Daly, J. W. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00878-7 · Cited by 20
Li, J., Flotildes, K., Li, M., & Cohen, B. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01578.x · Cited by 19
Fitch, R. W., Pei, X., Kaneko, Y., Gupta, T., Shi, D., Federova, I., & Daly, J. W. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.015 · Cited by 20
Abdrakhmanova, G. R., Damaj, M. I., Carroll, F. I., & Martin, B. R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021782 · Cited by 18
Rapacz, A., Kamiński, K., Obniska, J., Koczurkiewicz, P., Pękala, E., & Filipek, B. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1358-3 · Cited by 18
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Filchakova, O., & McIntosh, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064655 · Cited by 15
Pharmacology of neuronal nicotinic acetylcholine receptors: Effect of acute and chronic nicotine
Kellar, K. J., Dávila‐García, M. I., & Xiao, Y. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011921 · Cited by 14
Harkness, P. C., & Millar, N. S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00042-9 · Cited by 14
Herrera‐Arozamena, C., Estrada, M., Martí‐Marí, O., Pérez, C., Revenga, M. D. L. F., Villalba‐Galea, C. A., & Rodrı́guez-Franco, M. I. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112403 · Cited by 13
The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite
Fodale, V., & Santamaria, L. B. (2003) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.00139.x · Cited by 12
Reducing Auditory Nerve Excitability by Acute Antagonism of Ca2+-Permeable AMPA Receptors
Walia, A., Lee, C., Hartsock, J. J., Goodman, S. S., Dolle, R. E., Salt, A. N., Lichtenhan, J. T., & Rutherford, M. A. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.680621 · Cited by 11
De novo generation of dual-target compounds using artificial intelligence
Yasuda, K., Berenger, F., Amaike, K., Ueda, A., Nakagomi, T., Hamasaki, G., Li, C., Otani, N. Y., Kaitoh, K., Tsuda, K., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111526 · Cited by 10
Quinlivan, M., Chalon, S., Vergote, J., Henderson, J. M., Katsifis, A. G., Kassiou, M., & Guilloteau, D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.065 · Cited by 10
Levin, E. D., Wells, C., Johnson, J. E., Rezvani, A. H., Bymaster, F. P., & Rose, J. E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.041 · Cited by 10
Phosphorimaging detection and quantitation for isotopic ion flux assays
Fitch, R. W., & Daly, J. W. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.041 · Cited by 10
What we have learned from crystal structures of proteins to receptor function
Reymond, J., van Deursen, R., & Bertrand, D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.061 · Cited by 8
Lewis, J. A., Yakel, J. L., & Pandya, A. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161201145648 · Cited by 7
Sidach, S. S., Fedorov, N. B., Lippiello, P. M., & Bencherif, M. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.05.014 · Cited by 7
Zambrano, C. A., Salamander, R. M., Collins, A. C., Grady, S. R., & Marks, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192542 · Cited by 7
Iptakalim as a Human Nicotinic Acetylcholine Receptor Antagonist
Hu, J., Lindenberger, K. A., Hu, G., Wang, H., Lukas, R. J., & Wu, J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094987 · Cited by 7
Agonists and Antagonists of Nicotinic Acetylcholine Receptors
Arnerić, S. P., & Holladay, M. W. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_16 · Cited by 5
Zheng, C. J., Wang, M., Liu, Q., Wakui, M., Whiteaker, P., Lukas, R. J., & Wu, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05903.x · Cited by 5
Evaluation of Novel Nicotine Analogues for their Anti-Bacterial and Anti-Fungal Activity
Athmaram, T. N. (2016) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2016.03.00079 · Cited by 4
HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats
Lustyk, K., Sałaciak, K., Jakubczyk, M., Jastrzębska‐Więsek, M., Partyka, A., Wesołowska, A., Marona, H., & Pytka, K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03802-x · Cited by 4
Radioligand Binding Characterization of Neuronal Nicotinic Acetylcholine Receptors
Anderson, D. J. (2008) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0108s43 · Cited by 3
Vann, R. E., Tobey, K. M., Lobe, S., Kipps, B. R., Kwilasz, A. J., Aceto, M. D. G., & Harris, L. S. (2010) · Drug Development Research · doi:10.1002/ddr.20431 · Cited by 3
Neuronal Nicotinic Receptors: One Hundred Years of Progress
Kellar, K. J., & Xiao, Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn004 · Cited by 3
Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia
Fodale, V., Praticò, C., & Santamaria, L. B. (2004) · European Journal of Anaesthesiology · doi:10.1097/00003643-200404000-00022 · Cited by 3
Luque-Sanchez, K., Felix, J. S., Bilbrey, J. A., Restrepo, L., Reeves, M. E., McMahon, L. R., & Wilkerson, J. L. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11622 · Cited by 2
Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia
Fodale, V., Praticò, C., & Santamaria, L. B. (2004) · European Journal of Anaesthesiology · doi:10.1017/s0265021504314122 · Cited by 2
NEUROTRANSMITTERS AND RECEPTORS AS THE TARGETS FOR ADDICTION TREATMENT: A SHORT REVIEW
Bonam, S. R., Kumar, M. S. A., Rao, N., Babu, A. N., Rao, N. R., & Manjunathan, J. (2013) · Cited by 1
Fodale, V., Praticò, C., Signer, M. R., & Santamaria, L. B. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050500198436 · Cited by 1
Pharmakologische und nicht-pharmakologische Effekte auf die Kognition
Both, C. (2013) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
Progress in the development of potent and selective cholinergic channel modulators (ChCMs)
Holladay, M. W., Lin, N., Sullivan, J. P., Donnelly‐Roberts, D. L., Decker, M. W., Brioni, J. D., Ferrero, J. L., Rodrigues, A. D., Marsh, K. G., Buccafusco, J. G., et al. (1997) · Pharmacochemistry library · doi:10.1016/s0165-7208(97)80059-1
Buisson, B., Bertrand, S., & Bertrand, D. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(99)80029-1
REVIEW ARTICLE Alzheimer’s disease and anaesthesia: implications for the central cholinergic system
Fodale, V., Quattrone, D., Trecroci, C., Caminiti, V., & Santamaria, L. B. (2006)
Orac, C. M. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Nicotinic acetylcholine receptors, beta-adrenergic receptors and lung cancer
Schuller, H. M. (2002) · CRC Press eBooks · doi:10.1201/9780203219096-15
Expression, Pharmacological and Physiological Properties of Nicotinic Acetylcholine Receptors
Filchakova, O. (2014) · J. Willard Marriott Library · doi:10.26053/0h-qp7j-g500
Fodale, V., Praticò, C., Leto, G., Caminiti, V., Mazzeo, A. T., & Lucanto, T. (2004) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2004.10.005
Hosur, V. (2009) · Digital Repository Service (Northeastern University) · doi:10.17760/d20000672
BindingDB Entry 50000177: Structure-Based Design and Discovery of New M
BindingDB (2019) · UC San Diego · doi:10.7270/q2445pw2
The Effects of β-Amyloid on α7 Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
Anderson, M. L. (2011) · ScholarsArchive (Brigham Young University)
Regulation of Neuronal Nicotinic Receptor Expression by Novel Ligands and Mechanisms
Hussmann, G. P. (2012) · DigitalGeorgetown (Georgetown University Library)
Metadata
- Authors
- Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P.
- Affiliations
- Abbott (United States) (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1996-01
- Volume
- 276
- Issue
- 1
- Pages
- 289-297
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2238918217
- Cited by
- 178
- References
- 0
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2017: 4 · 2016: 6 · 2015: 2 · 2014: 2 · 2013: 7 · 2012: 3
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- neuronal nicotinic acetylcholine receptors, alpha4beta2 nAChR, nicotine, 86Rb efflux, ion channel function, receptor desensitization, receptor resensitization, receptor internalization, receptor trafficking
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Azocines, Base Sequence, Cells, Cultured, Humans, Kidney, Kinetics, Male, Molecular Sequence Data, Neurons, Nicotine, Quinolizines, Receptors, Nicotinic, RNA, Messenger, Stereoisomerism, Transfection, Tritium, Up-Regulation, Rats, Sprague-Dawley, DNA, Complementary, Nicotinic Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review